vimarsana.com

Page 9 - நாள்பட்ட தடைசெய்யும் நுரையீரல் கோளாறு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

PAOG Announces Puerto Rico Consortium For Clinical Investigation Engagement To Advance CBD COPD Nutraceutical Care Solution

PAOG Announces Puerto Rico Consortium For Clinical Investigation Engagement To Advance CBD COPD Nutraceutical Care Solution
marketwatch.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketwatch.com Daily Mail and Mail on Sunday newspapers.

PAOG Targets First Revenue From $12 7 Billion Market Selling CBD COPD Nutraceutical Care Product Line

Share this article Share this article SANDUSKY, Ohio, Dec. 18, 2020 /PRNewswire/ PAO Group, Inc. (USOTC: PAOG) today announced the company expects to generate its first revenue next year in 2021 from its Cannabidiol (CBD) extraction technology, RespRx, acquired in July of this year, 2020. Yesterday, PAOG announced an engagement with the Puerto Rico Consortium for Clinical Investigation (PRCCI) to assist PAOG with developing its proprietary CBD extract into a nutraceutical product to provide care for those experiencing issues associated with Chronic Obstructive Pulmonary Disorder (COPD). PAOG, through its engagement with PRCCI expects to rapidly produce its CBD COPD Nutraceutical product and establish sales. Grand View Research forecasts the CBD Nutraceutical marketplace reaching a value of $12.7 billion by 2025.

United States Mechanical Ventilators Market Report 2020: Manufacturers are Bracing up to Multiply the Production Capacity to Meet the Rising Demand to Overcome the COVID-19 Outbreak

Share this article Share this article ResearchAndMarkets.com s offering. The U.S. mechanical ventilators market size is expected to reach USD 1.71 billion by 2027, according to a new report by Grand View Research Inc. It is expected to expand at a CAGR of 3.0% from 2022 to 2027. The rising number of hospitalizations due to the coronavirus pandemic and increased need for ventilation among patients in the U.S. are expected to boost the adoption of mechanical ventilators. One of the key driving factors is the rising prevalence of respiratory diseases, which is expected to have a significant impact on market growth. The adoption of long-term Home Mechanical Ventilation (HMV) in case of chronic respiratory failure due to diseases, such as thoracic disease, Chronic Obstructive Pulmonary Disorder (COPD), and neuromuscular disease, is expected to increase over the forecast period.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.